Skip to main content

Advertisement

SpringerLink
Log in

The Relative Net Health Benefit of Liver Resection, Ablation, and Transplantation for Early Hepatocellular Carcinoma

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

There are no conclusive cost-effectiveness studies measuring the efficacy of salvage LT after liver resection (LR) and radiofrequency ablation (RFA) in patients with early hepatocellular carcinoma (HCC) and compensated cirrhosis. The aim of the present study is to compare liver transplantation (LT) versus locoregional therapy plus salvage LT (to treat tumor recurrence) in patients with early HCC and compensated cirrhosis.

Methods

Reference case: 55-year old male with HCC within Milan criteria and Child-Pugh A cirrhosis. The analysis was performed in two geographical cost settings: USA and Italy. Survival benefit measured in quality-adjusted life years (QALYs), costs (C) in US$, incremental cost-effectiveness, willingness to pay, and net health benefit (NHB).

Results

In the base-case analysis, NHB of LT vs. LR and RFA was −1.7 and −1.3 years for single tumor ≤3 cm, −1.2 and −0.7 for single nodules measuring 3.1–5 cm and −0.7 and −0.7 for multi-nodular tumor ≤3 cm in Italy. In USA, NHB of LT versus LR and RFA were −1.2 and −0.8 years for single tumor ≤3 cm, −0.9 and −0.5 for single nodules measuring 3.1–5 cm, and −0.5 and −0.4 for multi-nodular tumor ≤ 3 cm. On the Monte Carlo simulation, only young patients with multi-nodular HCC and short waiting list time had a positive NHB. Salvage LT proved to be an ineffective cost strategy after RFA or LR.

Conclusion

In patients with HCC within Milan criteria and Child-Pugh A cirrhosis, LR and RFA were more cost-effective than LT. Salvage LT was not cost-effective.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–699

    Article  CAS  PubMed  Google Scholar 

  2. Bruix J, Sherman M (2011) American Association for the Study of Liver D Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022

    Article  PubMed Central  PubMed  Google Scholar 

  3. Forner A, Hessheimer AJ, Isabel Real M et al (2006) Treatment of hepatocellular carcinoma. Crit Rev Oncol Hematol 60:89–98

    Article  PubMed  Google Scholar 

  4. Nathan H, Bridges JF, Schulick RD et al (2011) Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol 29:619–625

    Article  PubMed  Google Scholar 

  5. Adam R, Bhangui P, Vibert E et al (2012) Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy? Ann Surg 256:883–891

    Article  PubMed  Google Scholar 

  6. Bismuth H, Chiche L, Adam R et al (1993) Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 218:145–151

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Cherqui D, Laurent A, Mocellin N et al (2009) Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg 250:738–746

    Article  PubMed  Google Scholar 

  8. Park YK, Kim BW, Wang HJ et al (2009) Hepatic resection for hepatocellular carcinoma meeting Milan criteria in Child-Turcotte-Pugh class a patients with cirrhosis. Transpl Proc 41:1691–1697

    Article  Google Scholar 

  9. Cunningham SC, Tsai S, Marques HP et al (2009) Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis. Ann Surg Oncol 16:1820–1831

    Article  PubMed  Google Scholar 

  10. Ni JY, Xu LF, Sun HL et al (2013) Percutaneous ablation therapy versus surgical resection in the treatment for early-stage hepatocellular carcinoma: a meta-analysis of 21,494 patients. J Cancer Res Clin Oncol 139:2021–2033

    Article  PubMed  Google Scholar 

  11. Cucchetti A, Piscaglia F, Cescon M et al (2013) Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J Hepatol 59:300–307

    Article  PubMed  Google Scholar 

  12. Lim KC, Wang VW, Siddiqui FJ, et al.(2014) Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria. Hepatology. doi:10.1002/hep.27135

  13. Stinnett AA (1998) Mullahy J Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 18:S68–S80

    Article  CAS  PubMed  Google Scholar 

  14. Grosse SD (2008) Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res 8:165–178

    Article  PubMed  Google Scholar 

  15. Lang K, Danchenko N, Gondek K et al (2009) The burden of illness associated with hepatocellular carcinoma in the United States. J Hepatol 50:89–99

    Article  PubMed  Google Scholar 

  16. Mazzaferro V, Llovet JM, Miceli R et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35–43

    Article  PubMed  Google Scholar 

  17. Onaca N, Davis GL, Goldstein RM et al (2007) Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl 13:391–399

    Article  PubMed  Google Scholar 

  18. Volk ML, Vijan S, Marrero JA (2008) A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria American journal of transplantation. J Am Soc Transpl Am Soc Transpl Surg 8:839–846

    Article  CAS  Google Scholar 

  19. Beck JR, Kassirer JP, Pauker SG (1982) A convenient approximation of life expectancy (the “DEALE”). I. Validation of the method. Am J Med 73:883–888

  20. Salvalaggio PR, Dzebisashvili N, MacLeod KE et al (2011) The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation. Liver Transpl 17:233–242

    Article  PubMed  Google Scholar 

  21. Trotter JF, Mackenzie S, Wachs M et al (2003) Comprehensive cost comparison of adult-adult right hepatic lobe living-donor liver transplantation with cadaveric transplantation. Transplantation 75:473–476

    Article  PubMed  Google Scholar 

  22. Sagmeister M, Mullhaupt B, Kadry Z et al (2002) Cost-effectiveness of cadaveric and living-donor liver transplantation. Transplantation 73:616–622

    Article  PubMed  Google Scholar 

  23. Sagmeister M, Renner EL, Mullhaupt B et al (2002) Simulation of hepatitis C based on a mandatory reporting system. Eur J Gastroenterol Hepatol 14:25–34

    Article  PubMed  Google Scholar 

  24. Majno PE, Sarasin FP, Mentha G et al (2000) Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology 31:899–906

    Article  CAS  PubMed  Google Scholar 

  25. Fuks D, Dokmak S, Paradis V et al (2012) Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology 55:132–140

    Article  PubMed  Google Scholar 

  26. N’Kontchou G, Aout M, Laurent A et al (2012) Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis. J Hepatol 56:160–166

    Article  PubMed  Google Scholar 

  27. Vitale A, Volk ML, Pastorelli D et al (2010) Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety. Hepatology 51:165–173

    Article  CAS  PubMed  Google Scholar 

  28. Erlinge D, Gotberg M, Lang I et al (2014) Rapid endovascular catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction. The CHILL-MI trial: a randomized controlled study of the use of central venous catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction. J Am Coll Cardiol 63:1857–1865

    Article  PubMed  Google Scholar 

  29. Fenwick E, O’Brien BJ, Briggs A (2004) Cost-effectiveness acceptability curves–facts, fallacies and frequently asked questions. Health Econ 13:405–415

    Article  PubMed  Google Scholar 

  30. Siegel JE, Weinstein MC, Russell LB et al (1996) Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA 276:1339–1341

    Article  CAS  PubMed  Google Scholar 

  31. Cucchetti A, Piscaglia F, Cescon M et al (2013) Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol 19:4106–4118

    Article  PubMed Central  PubMed  Google Scholar 

  32. Nathan H, Segev DL, Mayo SC et al (2012) National trends in surgical procedures for hepatocellular carcinoma: 1998-2008. Cancer 118:1838–1844

    Article  PubMed  Google Scholar 

  33. Washburn K, Edwards E, Harper A et al (2010) Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transpl 10:1643–1648

    Article  CAS  Google Scholar 

  34. Landman MP, Feurer ID, Pinson CW et al (2011) Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria? HPB 13:783–791

    Article  PubMed Central  PubMed  Google Scholar 

  35. Zimmerman MA, Ghobrial RM, Tong MJ et al (2008) Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators Archives of surgery 143:182–188 discussion 188

  36. Cha CH, Ruo L, Fong Y et al (2003) Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg 238:315–321 discussion 321-313

    PubMed Central  PubMed  Google Scholar 

  37. Xu XS, Liu C, Qu K et al (2014) Liver transplantation versus liver resection for hepatocellular carcinoma: a meta-analysis. Hepatobiliary Pancreat Dis Int 13:234–241

    Article  PubMed  Google Scholar 

  38. Izumi R, Shimizu K, Ii T et al (1994) Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 106:720–727

    CAS  PubMed  Google Scholar 

  39. Cucchetti A, Vitale A, Del Gaudio M et al (2010) Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transpl 10:619–627

    Article  CAS  Google Scholar 

  40. Buscarini L, Buscarini E, Di Stasi M et al (2001) Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 11:914–921

    Article  CAS  PubMed  Google Scholar 

  41. Lencioni R, Cioni D, Crocetti L et al (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–967

    Article  PubMed  Google Scholar 

  42. Chou CT, Chou JM, Chang TA et al (2013) Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging. World J Gastroenterol 19:7433–7439

    Article  PubMed Central  PubMed  Google Scholar 

  43. Poon RT, Fan ST, Lo CM et al (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235:373–382

    Article  PubMed Central  PubMed  Google Scholar 

  44. Chan AC, Chan SC, Chok KS et al (2013) Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation? Liver transpl 19:411–419

    Article  PubMed  Google Scholar 

  45. Polesel J, Zucchetto A, Montella M et al (2009) The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol 20:353–357

    Article  CAS  PubMed  Google Scholar 

  46. Naugler WE, Sonnenberg A (2010) Sonnenberg a survival and cost-effectiveness analysis of competing strategies in the management of small hepatocellular carcinoma. Liver Transpl 16:1186–1194

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Author notes

    Authors and Affiliations

    1. Department of Surgery, The Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Blalock 688, Baltimore, MD, 21287, USA

      Gaya Spolverato, Aslam Ejaz, Yuhree Kim & Timothy M. Pawlik

    2. Unità di Chirurgia Epatobiliare e Trapianto Epatico, Azienda Ospedaliera-Università di Padova, Padua, Italy

      Alessandro Vitale

    3. Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA

      Shishir K. Maithel

    4. Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

      David P. Cosgrove

    Authors
    1. Gaya Spolverato
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Alessandro Vitale
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Aslam Ejaz
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Yuhree Kim
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Shishir K. Maithel
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. David P. Cosgrove
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Timothy M. Pawlik
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Timothy M. Pawlik.

    Additional information

    Authors Gaya Spolverato and Alessandro Vitale contributed equally to this work.

    Electronic supplementary material

    Below is the link to the electronic supplementary material.

    Supplementary material 1 (DOCX 104 kb)

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Spolverato, G., Vitale, A., Ejaz, A. et al. The Relative Net Health Benefit of Liver Resection, Ablation, and Transplantation for Early Hepatocellular Carcinoma. World J Surg 39, 1474–1484 (2015). https://doi.org/10.1007/s00268-015-2987-7

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s00268-015-2987-7

    Keywords

    Search

    Navigation